Bone Marrow TransplantationBone MarrowBone Marrow CellsTissue DonorsTransplantation, HomologousGraft vs Host DiseaseHistocompatibilityHistocompatibility TestingHematopoietic Stem Cell TransplantationLeukemiaBone and BonesWhole-Body IrradiationTransplantation ConditioningAnemia, AplasticGraft SurvivalHLA AntigensHematologic NeoplasmsHematopoietic Stem CellsTransplantation ChimeraLiving DonorsTransplantation, AutologousBone Marrow DiseasesBone Marrow ExaminationSevere Combined ImmunodeficiencyLymphocyte DepletionTreatment OutcomeTissue and Organ ProcurementGraft RejectionBlood DonorsCytomegalovirus InfectionsImmunosuppressive AgentsBone Marrow NeoplasmsRecurrenceBone Marrow PurgingImmunosuppressionLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveT-LymphocytesTime FactorsGraft vs Host ReactionAcute DiseaseBone RemodelingHaploidyHematopoiesisPrecursor Cell Lymphoblastic Leukemia-LymphomaRetrospective StudiesCord Blood Stem Cell TransplantationMice, Inbred C57BLLeukocyte TransfusionImmunocompromised HostOpportunistic InfectionsLymphocyte TransfusionRadiation ChimeraHaplotypesColony-Forming Units AssayPeripheral Blood Stem Cell TransplantationCyclophosphamideCyclosporineDisease-Free SurvivalSurvival AnalysisAntilymphocyte SerumKidney TransplantationAntigens, CD34Bone DensityBusulfanMycosesGraft vs Leukemia EffectSurvival RateCytomegalovirusRegistriesTransplantation, IsogeneicCell DifferentiationFetal TherapiesFatal OutcomeHematologic DiseasesBone ResorptionRemission InductionMyelodysplastic SyndromesNuclear FamilyLeukemia, MyeloidStem Cell TransplantationPneumonia, ViralCells, CulturedCombined Modality TherapyUnrelated DonorsGranulocyte Colony-Stimulating FactorFlow CytometryGanciclovirSiblingsSpleenAspergillosisPolymerase Chain ReactionFollow-Up StudiesHepatic Veno-Occlusive DiseaseBone NeoplasmsBlood Group IncompatibilityGranulocytesLymphoma, Non-HodgkinLeukocyte CountTransplants